DHACOPAN SYRUP 5mg/5ml

Product Information

Registration Status: Active

DHACOPAN SYRUP 5mg/5ml is approved to be sold in Singapore with effective from 1989-05-31. It is marketed by DRUG HOUSES OF AUSTRALIA PTE LTD, with the registration number of SIN03115P.

This product contains Hyoscine Butylbromide 5mg/5ml in the form of SYRUP. It is approved for ORAL use.

This product is manufactured by PT ACTAVIS INDONESIA in INDONESIA REP OF.

It is a Pharmacy Only Medicine that can be obtained from a pharmacist at a retail pharmacy.

Hyoscine Butylbromide


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank